Atlas Venture Associates XI, LLC - Insider Non-Derivative Transactions at Xilio Therapeutics, Inc. (XLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 8, 2024, Atlas Venture Associates XI, LLC's relationship to Xilio Therapeutics, Inc. (XLO) is TenPercentOwner, and currently has 2,019,563 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other XLO insiders.
Data Source: SEC.
Atlas Venture Associates XI, LLC - Insider Non-Derivative Transactions at XLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 9, 2024 | Sell -- (Common Stock) | 267 | 0.64 | 734546 |
| Feb 9, 2024 | Sell -- (Common Stock) | 733 | 0.64 | 2019563 |